Abstract:Studies have shown that monomethoxy(polyethylene glycol)-poly(d,l-lactic-co-glycolic acid)-poly-(l-lysine) (mPEG-PLGA-PLL)-prepared nanoparticles (NPs) are promising drugs carriers, with good drug loading and delivery performance. To further promote the use of this material in clinical applications, its degradation and biosafety were evaluated. This paper describes degradation studies and biosafety evaluations of different block composition ratios (LA/GA = 60/40, 70/30, and 80/20) of the main material, PLGA, for mPEG-PLGA-PLL (PEAL) NPs. The degradation of PEAL NPs was studied by characterizing the change in molecular weight, the chemical composition, and the degradation rate in addition to the pH value, the particle size, the zeta potential, and the lactic acid and lysine contents in degradation solutions by transmission electron microscopy (TEM), gel permeation chromatography (GPC), and H-1 NMR. The results show that with prolonged degradation time, the pH, particle size, zeta potential, and molecular weight were reduced and that the lactic acid and lysine contents and the molecular weight distribution were increased. 1H NMR demonstrated that the hydrolysis rate for glycolic units was faster than those for lactic acid and lysine units. The degradation rate of NPs in pH 7.4 PBS was faster than that in pH 5.0 PBS. The degradation rate of PEAL NPs increased as the LA/GA increased from LA/GA = 60/40 to 80/20. Investigations of intracellular protein synthesis, lactate dehydrogenase (LDH) release, 4',6-diamidino-2-phenylindole (DAPI) nuclear staining and reactive oxygen species (ROS) content in Huh7, L02, and RAW 264.7 cells showed that the PEAL NPs had no effect on protein synthesis or cell membrane integrity and did not induce chromatin agglutination. Although the ROS content was slightly concentration-dependent and time-dependent, the change in content was minimal and diffusely distributed within the cell. After THP-1 cells were induced to differentiate into macrophages, a subsequent incubation with 5 mM PEAL NPs for 24 h did not significantly induce the macrophage release of IL-1 beta, TNF-alpha, and TGF-beta 1 compared with the negative control. Embryos that had their chorion removed were coincubated with PEAL NPs to determine if there were any effects on embryonic development. It is known that zebrafish embryos at 10-24 h post-fertilization (hpf) are most sensitive to PEAL NPs. Zebrafish embryos treated with different concentrations of PEAL NPs within this sensitive time frame demonstrated that PEAL NPs have a high level of biosafety. Our work demonstrates that PEAL NPs are safe candidates for use as biodegradable carriers for drug and gene delivery.

In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer

In Vitro Macrophage Uptake and in Vivo Biodistribution of PLA–PEG Nanoparticles Loaded with Hemoglobin As Blood Substitutes: Effect of PEG Content

Comparison of the Pla-Mpeg and Mpeg-Pla-Mpeg Copolymers Nanoparticles on the Plasma Protein Adsorption and in Vivo Biodistribution

Long-circulation of Hemoglobin-Loaded Polymeric Nanoparticles As Oxygen Carriers with Modulated Surface Charges

Influence of Different PEG Contents on the Phagocytic Uptake and Plasma Protein Adsorption of Mpeg-Plga-mpeg Nanoparticles

Degradation and Bio-Safety Evaluation of Mpeg-Plga-Pll Copolymer-Prepared Nanoparticles

The Biological Fate of the Polymer Nanocarrier Material Monomethoxy Poly(ethylene Glycol)-Block-poly(d,l-lactic Acid) in Rat

Long-circulating Polymeric Nanoparticles Bearing a Combinatorial Coating of PEG and Water-Soluble Chitosan.

Cytotoxicity and Hemocompatibility of A Family of Novel Meo-Peg-Poly (D,l-Lactic-co-glycolic Acid)-Peg-Ome Triblock Copolymer Nanoparticles

The biocompatibility evaluation of mPEG-PLGA-PLL copolymer and different LA/GA ratio effects for biocompatibility.

Releasing characterization, pharmacokinetics and distribution of PEG-PBLG copolymer micelles in vitro and in vivo

Body Distribution and in Situ Evading of Phagocytic Uptake by Macrophages of Long-Circulating Poly (ethylene Glycol) Cyanoacrylate-Co-n-hexadecyl Cyanoacrylate Nanoparticles.

Modifying the Backbone Chemistry of PEG‐based Bottlebrush Block Copolymers for the Formation of Long‐Circulating Nanoparticles

The effect of surface poly(ethylene glycol) length on in vivo drug delivery behaviors of polymeric nanoparticles.

The Impact of PEGylation Patterns on the in Vivo Biodistribution of Mixed Shell Micelles

Pharmacokinetics and disposition of nanomedicine using biodegradable PEG/PCL polymers as drug carriers.

PEG Branched Polymer for Functionalization of Nanomaterials with Ultralong Blood Circulation

Influence of PEG Chain on the Complement Activation Suppression and Longevity in Vivo Prolongation of the PCL Biomedical Nanoparticles

Efficient internalization of poly(benzyl malate) and poly(ethylene glycol)-b-poly(benzyl malate) copolymer based nanoparticles by human hepatic HepaRG cells and macrophages : Impact of nanoparticle functionalization by GBVA10-9 peptide on cell uptake.

Influence of Polyethyleneglycol Modification on Phagocytic Uptake of Polymeric Nanoparticles Mediated by Immunoglobulin G and Complement Activation.

A Comparative in Vitro Evaluation of Self-Assembled PTX-PLA and PTX-MPEG-PLA Nanoparticles.